Cited by 2,641Clostridium difficile and Clostridium perfringens researchInfection Control in HealthcareAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Burden of Clostridium difficile Infection in the United States

Open access

Lessa, Fernanda C., Mu, Yi, Bamberg, Wendy M., Beldavs, Zintars G., Dumyati, Ghinwa K., Dunn, John R., Farley, Monica M., Holzbauer, Stacy M., Meek, James I., Phipps, Erin C., Wilson, Lucy E., Winston, Lisa G., Cohen, Jessica A., Limbago, Brandi M., Fridkin, Scott K., Gerding, Dale N., McDonald, L. Clifford·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1408913PMC PMC10966662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001). CONCLUSIONS: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1408913

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citation
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,965
Self-citation
Sampling: Design and Analysis
Ziegel, E. R., & Lohr, S. L. (2000) · Technometrics · doi:10.2307/1271491 · Cited by 2,452
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020
Self-citation
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,962
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,049
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, A., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 838
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R. P., Gerding, D. N., Nichol, G. M., Thomas, W. D., Leney, M. D., Sloan, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 743
Self-citation
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 566
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
Planche, T., Davies, K., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O’Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 436

Show all 44 references

Research works printed but not linked: 4

2005, MMWR Morb Mortal Wkly Rep, 54, 1201
Heitjan DF, 1991, J R Stat Soc Ser C Appl Stat, 40, 13
2014, Fed Regist, 79, 10524
2011, Fed Regist, 76, 51476

Sorted by citations

Items 101–200 of 1,002

The role of vaccines in fighting antimicrobial resistance (AMR)
Jansen, K. U., & Anderson, A. S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1476814 · Cited by 158
Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
Neumann‐Schaal, M., Jahn, D., & Schmidt‐Hohagen, K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00219 · Cited by 145
Bibliometric analysis of peer-reviewed literature on antimicrobial stewardship from 1990 to 2019
Sweileh, W. M. (2021) · Globalization and Health · doi:10.1186/s12992-020-00651-7 · Cited by 162
Infections in the Elderly Critically-Ill Patients
Eşme, M., Topeli̇, A., Doğu, B. B., & Akova, M. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00118 · Cited by 157
Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute
Khanna, S., Shin, A., & Kelly, C. P. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.024 · Cited by 156
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth
Weingarden, A. R., Dosa, P. I., DeWinter, E., Steer, C. J., Shaughnessy, M. K., Johnson, J. R., Khoruts, A., & Sadowsky, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147210 · Cited by 160
Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
Zhu, D., Sorg, J. A., & Sun, X. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00029 · Cited by 168
Mucosal vaccines and technology
Miquel-Clopés, A., Bentley, E. G., Stewart, J. P., & Carding, S. R. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13285 · Cited by 153
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions
Ianiro, G., Masucci, L., Quaranta, G., Simonelli, C., Lopetuso, L. R., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14816 · Cited by 152
Comparison of pediatric and adult antibiotic-associated diarrhea andClostridium difficileinfections
McFarland, L. V., Özen, M., Dinleyici, E. Ç., & Goh, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3078 · Cited by 163
Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
Hirsch, B. E., Saraiya, N., Poeth, K., Schwartz, R. M., Epstein, M. E., & Honig, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0930-z · Cited by 158
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group
Doi, Y., Bonomo, R. A., Hooper, D. C., Kaye, K. S., Johnson, J. R., Clancy, C. J., Thaden, J. T., Stryjewski, M. E., & van Duin, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw829 · Cited by 151
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
Winston, J. A., & Theriot, C. M. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.003 · Cited by 155
Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections
Hocquart, M., Lagier, J., Cassir, N., Saïdani, N., Eldin, C., Kerbaj, J., Delord, M., Valles, C., Brouqui, P., Raoult, D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix762 · Cited by 150
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
Shogbesan, O., Poudel, D. R., Victor, S., Jehangir, A., Fadahunsi, O., Shogbesan, G., & Donato, A. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/1394379 · Cited by 149
Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection
Buonomo, E. L., Cowardin, C. A., Wilson, M. G., Saleh, M. M., Pramoonjago, P., & Petri, W. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.007 · Cited by 152
Reorganisation of Faecal Microbiota Transplant Services During the COVID-19 Pandemic
Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321829 · Cited by 147
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Kociolek, L. K., & Gerding, D. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.220 · Cited by 156
Self-citation
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease
Seekatz, A. M., Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.00459-15 · Cited by 141
Clostridium difficile Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes
Jenior, M. L., Leslie, J. L., Young, V. B., & Schloss, P. D. (2017) · mSystems · doi:10.1128/msystems.00063-17 · Cited by 140
Physical activity induced alterations of gut microbiota in humans: a systematic review
Dziewiecka, H., Buttar, H. S., Kasperska, A., Ostapiuk–Karolczuk, J., Domagalska, M., Cichoń-Woźniak, J., & Skarpańska-Stejnborn, A. (2022) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-022-00513-2 · Cited by 155
Burden of Clostridium difficile Infection in the United States
Bouwknegt, M., van Dorp, S., & Kuijper, E. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505190 · Cited by 142
Faecal microbiota transplant for recurrentClostridium difficileinfection using long-term frozen stool is effective: clinical efficacy and bacterial viability data
Costello, S. P., Conlon, M. A., Vuaran, M. S., Roberts-Thomson, I. C., & Andrews, J. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13366 · Cited by 143
Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience
Cheng, Y., Phelps, E. L., Ganapini, V., Khan, N. U. A., Ouyang, F., Xu, H., Khanna, S., Tariq, R., Friedman‐Moraco, R., Woodworth, M. H., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15058 · Cited by 141
Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
Bourgin, M., Kriaa, A., Mkaouar, H., Mariaule, V., Jablaoui, A., Maguin, E., & Rhimi, M. (2021) · Microorganisms · doi:10.3390/microorganisms9061122 · Cited by 152
Results from a randomized placebo-controlled clinical trial of a RBX2660-a microbiota-based drug for the prevention of recurrent Clostridium difficile infection
Dubberke, E. R., Lee, C. H., Orenstein, R., Khanna, S., Hecht, G., & Gerding, D. N. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy259 · Cited by 140
Self-citation
Chemical Strategies To Target Bacterial Virulence
Garland, M., Loscher, S., & Bogyo, M. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00676 · Cited by 142
A small-molecule antivirulence agent for treating Clostridium difficile infection
Bender, K. O., Garland, M., Ferreyra, J. A., Hryckowian, A. J., Child, M. A., Puri, A. W., Solow-Cordero, D. E., Higginbottom, S. K., Segal, E., Banaei, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9103 · Cited by 136
Incidence and Outcomes Associated With Clostridium difficile Infections
Marra, A. R., Perencevich, E. N., Nelson, R. E., Samore, M. H., Khader, K., Chiang, H., Chorazy, M. L., Herwaldt, L. A., Diekema, D. J., Kuxhausen, M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17597 · Cited by 149
Clostridioides difficile Infection
Guh, A. Y., & Kutty, P. K. (2018) · Annals of Internal Medicine · doi:10.7326/aitc201810020 · Cited by 144
Effects of short‐term endurance exercise on gut microbiota in elderly men
Taniguchi, H., Tanisawa, K., Sun, X., Kubo, T., Hoshino, Y., Hosokawa, M., Takeyama, H., & Higuchi, M. (2018) · Physiological Reports · doi:10.14814/phy2.13935 · Cited by 144
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Frisbee, A. L., Saleh, M. M., Young, M. K., Leslie, J. L., Simpson, M. D., Abhyankar, M. M., Cowardin, C. A., Ma, J. Z., Pramoonjago, P., Turner, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10733-9 · Cited by 134
Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed
Freedberg, D. E., Salmasian, H., Cohen, B., Abrams, J. A., & Larson, E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6193 · Cited by 133
Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review
Woodworth, M. H., Carpentieri, C., Sitchenko, K. L., & Kraft, C. S. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1286006 · Cited by 136
A probiotic yeast-based immunotherapy against Clostridioides difficile infection
Chen, K., Zhu, Y., Zhang, Y., Hamza, T., Yu, H., Fleur, A. S., Galen, J. E., Yang, Z., & Feng, H. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax4905 · Cited by 131
Pathogenicity and virulence of Clostridioides difficile
Buddle, J. E., & Fagan, R. P. (2022) · Virulence · doi:10.1080/21505594.2022.2150452 · Cited by 147
Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update
Napolitano, L. M., & Edmiston, C. E. (2017) · Surgery · doi:10.1016/j.surg.2017.01.018 · Cited by 132
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial
Baunwall, S. M. D., Paaske, S. E., Hansen, M. M., Kelsen, J., Høyer, K. L., Rågård, N., Eriksen, L. L., Støy, S. H., Rubak, T., Damsgaard, E. M. S., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00276-x · Cited by 138
An Overview of Healthcare Associated Infections and Their Detection Methods Caused by Pathogen Bacteria in Romania and Europe
Szabó, S., Feier, B., Capatina, D., Tertiş, M., Cristea, C., & Popa, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113204 · Cited by 128
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children
Davidovics, Z. H., Michail, S. K., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 132
Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome
Cabral, D. J., Penumutchu, S., Reinhart, E. M., Zhang, C., Korry, B. J., Wurster, J. I., Nilson, R., Guang, A., Sano, W. H., Rowan-Nash, A. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.020 · Cited by 132
Antiviral and Antibacterial Nanostructured Surfaces with Excellent Mechanical Properties for Hospital Applications
Hasan, J., Xu, Y., Yarlagadda, T., Schuetz, M., Spann, K. M., & Yarlagadda, P. K. D. V. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00348 · Cited by 133
Faecal microbiota transplantation for Clostridium difficile ‐associated diarrhoea: a systematic review of randomised controlled trials
Moayyedi, P., Yuan, Y., Baharith, H., & Ford, A. C. (2017) · The Medical Journal of Australia · doi:10.5694/mja17.00295 · Cited by 128
Advances in optimizing the prescription of antibiotics in outpatient settings
King, L., Fleming-Dutra, K. E., & Hicks, L. A. (2018) · BMJ · doi:10.1136/bmj.k3047 · Cited by 129
Sporulation and Germination in Clostridial Pathogens
Shen, A., Edwards, A. N., Sarker, M. R., & Paredes‐Sabja, D. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0017-2018 · Cited by 126
Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
Khanna, S., Montassier, E., Schmidt, B. A., Patel, R., Knights, D., Pardi, D. S., & Kashyap, P. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13750 · Cited by 127
Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection
Vincent, C., Miller, M. A., Edens, T. J., Mehrotra, S., Dewar, K., & Manges, A. R. (2016) · Microbiome · doi:10.1186/s40168-016-0156-3 · Cited by 124
A Generalizable, Data-Driven Approach to Predict Daily Risk ofClostridium difficileInfection at Two Large Academic Health Centers
Oh, J., Makar, M., Fusco, C., McCaffrey, R., Rao, K. K., Ryan, E. E., Washer, L., West, L. R., Young, V. B., Guttag, J. V., et al. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.16 · Cited by 124
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact
Borren, N. Z., Ghadermarzi, S., Hutfless, S. M., & Ananthakrishnan, A. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176797 · Cited by 123
Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014
Bcheraoui, C. E., Mokdad, A. H., Dwyer‐Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Shirude, S., Naghavi, M., & Murray, C. J. L. (2018) · JAMA · doi:10.1001/jama.2018.2089 · Cited by 123
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children
Nicholson, M. R., Mitchell, P. D., Alexander, E., Ballal, S. A., Bartlett, M., Becker, P., Davidovics, Z. H., Docktor, M., Dole, M., Felix, G., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.037 · Cited by 125
Antibiotic treatment of acute gastroenteritis in children
Bruzzese, E., Giannattasio, A., & Guarino, A. (2018) · F1000Research · doi:10.12688/f1000research.12328.1 · Cited by 122
“Cd is also responsible for self-limiting, sporadic cases of AGE in children, although its pathogenic role is limited or questionable in children under 36 months of age because of the high frequency of carriers 35 .”
Background
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
Vickers, R. J., Tillotson, G., Nathan, R., Hazan, S., Pullman, J. R., LUCASTI, C. J., Deck, K., Yacyshyn, B., Maliakkal, B. J., Pesant, Y., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30235-9 · Cited by 127
Self-citation
Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China
Jin, D., Luo, Y., Huang, C., Cai, J., Ye, J., Zheng, Y. F., Wang, L., Zhao, P., Liu, A., Fang, W. J., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01898-16 · Cited by 120
How to: diagnose infection caused by Clostridium difficile
Gateau, C., Couturier, J., Coia, J. E., & Barbut, F. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.005 · Cited by 121
Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies
Ofori, E., Ramai, D., Dhawan, M., Mustafa, F. A. M., Gasperino, J., & Reddy, M. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.01.015 · Cited by 121
Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation
Deng, H., Yang, S., Zhang, Y., Qian, K., Zhang, Z., Liu, Y., Wang, Y., Bai, Y., Fan, H., Zhao, X., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02976 · Cited by 123
Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection
Ke, S., Pollock, N. R., Wang, X., Chen, X., Daugherty, K., Lin, Q., Xu, H. J., Garey, K. W., Gonzales-Luna, A. J., Kelly, C. P., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1935186 · Cited by 120
Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
Seekatz, A. M., Rao, K. K., Santhosh, K., & Young, V. B. (2016) · Genome Medicine · doi:10.1186/s13073-016-0298-8 · Cited by 120
Protease-activated receptors in health and disease
Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W., & Schmidt, B. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00044.2021 · Cited by 116
Trehalose and its applications in the food industry
Chen, A., Tapia, H., Goddard, J. M., & Gibney, P. A. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13048 · Cited by 116
Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-Galvez, J., Vanga, R. R., Castillo, N. E., Hansen, J., Dennis, M., Leffler, D. A., & Kelly, C. P. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1267890 · Cited by 115
Antibiotic and pesticide susceptibility and the Anthropocene operating space
Living with Resistance project, Jørgensen, P. S., Aktipis, A., Brown, Z. S., Carrière, Y., Downes, S. J., Dunn, R. R., Epstein, G., Frisvold, G. B., Hawthorne, D. J., et al. (2018) · Nature Sustainability · doi:10.1038/s41893-018-0164-3 · Cited by 119
Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea
Silverman, M. A., Konnikova, L., & Gerber, J. S. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.010 · Cited by 118
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention
Revolinski, S., & Munoz-Price, L. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy845 · Cited by 111
Epigenomic characterization of Clostridioides difficile finds a conserved DNA methyltransferase that mediates sporulation and pathogenesis
Oliveira, P. H., Ribis, J. W., Garrett, E. M., Trzilova, D., Kim, A., Sekulović, O., Mead, E. A., Pak, T. R., Zhu, S., Deikus, G. Y., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0613-4 · Cited by 108
An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection
Antharam, V. C., McEwen, D. C., Garrett, T. J., Dossey, A. T., Li, E. C., Kozlov, A., Mesbah, Z., & Wang, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148824 · Cited by 113
Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review
McFarland, L. (2015) · Antibiotics · doi:10.3390/antibiotics4020160 · Cited by 109
Shifts in the Gut Metabolome and Clostridium difficile Transcriptome throughout Colonization and Infection in a Mouse Model
Fletcher, J. R., Erwin, S., Lanzas, C., & Theriot, C. M. (2018) · mSphere · doi:10.1128/msphere.00089-18 · Cited by 104
Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update
Kociolek, L. K., Gerding, D. N., Carrico, R., Carling, P., Donskey, C. J., Dumyati, G. K., Kuhar, D. T., Loo, V. G., Maragakis, L. L., Pogorzelska‐Maziarz, M., et al. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.18 · Cited by 112
Self-citation
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
Staley, C. M., Kaiser, T., Vaughn, B. P., Graiziger, C. T., Hamilton, M. J., Rehman, T. U., Song, K., Khoruts, A., & Sadowsky, M. J. (2018) · Microbiome · doi:10.1186/s40168-018-0549-6 · Cited by 108
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics
Ianiro, G., Murri, R., Sciumè, G. D., Impagnatiello, M., Masucci, L., Ford, A. C., Law, G. R., Tilg, H., Sanguinetti, M., Cauda, R., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3635 · Cited by 109
Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells
Tao, L., Tian, S., Zhang, J., Liu, Z., Robinson‐McCarthy, L. R., Miyashita, S.-I., Breault, D. T., Gerhard, R., Oottamasathien, S., Whelan, S. P. J., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0464-z · Cited by 106
Genomic Delineation of Zoonotic Origins of Clostridium difficile
Knight, D. R., & Riley, T. V. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00164 · Cited by 106
Clostridioides difficile: diagnosis and treatments
Guery, B. P., Galpérine, T., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 117
Establishing a Fecal Microbiota Transplant Service for the Treatment ofClostridium difficileInfection
Costello, S. P., Tucker, E. C., LaBrooy, J. T., Schoeman, M., & Andrews, J. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ994 · Cited by 108
Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection
Cao, F., Chen, C. X., Wang, M., Liao, H. R., Wang, M. X., Hua, S. Z., Huang, B., Xiong, Y., Zhang, J., & Xu, Y. L. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.08.017 · Cited by 105
Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection
Saleh, M. M., Frisbee, A. L., Leslie, J. L., Buonomo, E. L., Cowardin, C. A., Ma, J. Z., Simpson, M. D., Scully, K. W., Abhyankar, M. M., & Petri, W. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.03.003 · Cited by 102
AlGaN Deep-Ultraviolet Light-Emitting Diodes Grown on SiC Substrates
SaifAddin, B. K., Almogbel, A. S., Zollner, C. J., Wu, F., Bonef, B., Iza, M., Nakamura, S., DenBaars, S. P., & Speck, J. S. (2020) · ACS Photonics · doi:10.1021/acsphotonics.9b00600 · Cited by 105
Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection
Alonso, M. P., de la Fuente, J. S., Carlavilla, Á. L. R., Moreno-Nuñez, P., Martínez-García, L., Escudero-Sánchez, R., Pintor, R., Fernández, S. G., & Cobo, J. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.454 · Cited by 105
A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)
Barker, A., Duster, M. N., Valentine, S., Hess, T., Archbald‐Pannone, L. R., Guerrant, R. L., & Safdar, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx254 · Cited by 106
Clostridium difficile infection in the elderly: an update on management
Asempa, T. E., & Nicolau, D. P. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s149089 · Cited by 110
A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078
Dingle, K. E., Didelot, X., Quan, T. P., Eyre, D. W., Stoesser, N. E., Marwick, C., Coia, J. E., Brown, D., Buchanan, S. J., Ijaz, U. Z., et al. (2019) · mBio · doi:10.1128/mbio.02790-18 · Cited by 103
High risk of post‐infectious irritable bowel syndrome in patients with Clostridium difficile infection
Wadhwa, A., Alnahhas, M. F., Dierkhising, R., Patel, R., Kashyap, P., Pardi, D. S., Khanna, S., & Grover, M. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13737 · Cited by 102
‘Get in Early’; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages
Nale, J. Y., Chutia, M., Carr, P., Hickenbotham, P. T., & Clokie, M. R. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01383 · Cited by 102
A genetic switch controls the production of flagella and toxins in Clostridium difficile
Anjuwon-Foster, B. R., & Tamayo, R. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006701 · Cited by 102
Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay
Pollock, N. R., Banz, A., Chen, X., Williams, D. N., Xu, H. J., Cuddemi, C., Cui, A. X., Perrotta, M., Alhassan, E., Riou, B., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy415 · Cited by 102
Type IV Pili Promote Clostridium difficile Adherence and Persistence in a Mouse Model of Infection
McKee, R. W., Aleksanyan, N., Garrett, E. M., & Tamayo, R. (2018) · Infection and Immunity · doi:10.1128/iai.00943-17 · Cited by 101
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection
Webb, B. J., Subramanian, A. K., Lopansri, B. K., Goodman, B., Jones, P. B., Ferraro, J. P., Stenehjem, E. A., & Brown, S. M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02169-19 · Cited by 101
Clostridioides difficile
Sandhu, B. K., & McBride, S. M. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.09.004 · Cited by 100
Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance
Pedicord, V. A., Lockhart, A. A. K., Rangan, K. J., Craig, J. W., Loschko, J., Rogoz, A., Hang, H. C., & Mucida, D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aai7732 · Cited by 99
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
He, R., Li, P., Wang, J., Cui, B., Zhang, F., & Zhao, F. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2100197 · Cited by 98
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
Zhang, D., Prabhu, V. S., & Marcella, S. W. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1021 · Cited by 98
Antimicrobial Stewardship in the Emergency Department
Pulia, M. S., Redwood, R., & May, L. S. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2018.06.012 · Cited by 102
Bile acid-independent protection against Clostridioides difficile infection
Aguirre, A. M., Yalçınkaya, N., Wu, Q., Swennes, A. G., Tessier, M. E. M., Roberts, P., Miyajima, F., Savidge, T., & Sorg, J. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010015 · Cited by 95
Crystal structure of Clostridium difficile toxin A
Chumbler, N. M., Rutherford, S. A., Zhang, Z., Farrow, M. A., Lisher, J. P., Farquhar, E. R., Giedroc, D. P., Spiller, B. W., Melnyk, R. A., & Lacy, D. B. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.2 · Cited by 96
Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization
Jenior, M. L., Leslie, J. L., Young, V. B., & Schloss, P. D. (2018) · mSphere · doi:10.1128/msphere.00261-18 · Cited by 96
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Castro-Córdova, P., Mora-Uribe, P., Reyes-Ramírez, R., Cofré-Araneda, G., Orozco-Aguilar, J., Brito-Silva, C., Mendoza-León, M. J., Kuehne, S. A., Minton, N. P., Pizarro‐Guajardo, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21355-5 · Cited by 96
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
de Bruyn, G., Saleh, J., Workman, D., Pollak, R. A., Elinoff, V., Fraser, N. J., Lefebvre, G., Martens, M. G., Mills, R. E., Nathan, R., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.028 · Cited by 95
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study
Guh, A. Y., Adkins, S. H., Li, Q., Bulens, S. N., Farley, M. M., Smith, Z., Holzbauer, S., Whitten, T., Phipps, E. C., Hancock, E. B., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx171 · Cited by 95
Self-citation

Authors: Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., Wilson, L. E., Winston, L. G., Cohen, J. A., Limbago, B. M., Fridkin, S. K., Gerding, D. N., & McDonald, L. C.
Affiliations: National Center for Emerging and Zoonotic Infectious Diseases (US)
Colorado Department of Public Health and Environment (US)
Oregon Health Authority (US)
University of Rochester Medicine (US)
Tennessee Department of Health (US)
Emory University (US)
Office of Readiness and Response (US)
Yale University (US)
University of New Mexico (US)
Maryland Department of Health (US)
University of California, San Francisco (US)
Loyola University Chicago (US)
ORCID: Lessa, Fernanda C.
Mu, Yi
Bamberg, Wendy M.
Dumyati, Ghinwa K.
Dunn, John R.
Farley, Monica M.
Holzbauer, Stacy M.
Meek, James I.
Phipps, Erin C.
Wilson, Lucy E.
Fridkin, Scott K.
Gerding, Dale N.
McDonald, L. Clifford
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-02-26
Volume: 372
Issue: 9
Pages: 825-834
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1408913
PMC: PMC10966662
OpenAlex: W2071054182
Cited by: 2,641
References: 44
Citations by year: 2026: 94 · 2025: 111 · 2024: 120 · 2023: 150 · 2022: 176 · 2021: 225 · 2020: 328 · 2019: 382 · 2018: 356 · 2017: 323 · 2016: 262 · 2015: 108
FWCI: 270.42
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: New England Journal of Medicine (publishedVersion, other-oa)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Maryland Shared Open Access Repository (USMAI Consortium) (submittedVersion, public-domain)
eScholarship (California Digital Library) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park) (public-domain)
Funders: National Institutes of Health (CC999999)
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: Clostridium difficile infection, incidence, nosocomial infections, community-associated infections, recurrence, mortality, NAP1 strain, molecular typing, pulsed-field gel electrophoresis
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Clostridium Infections, Cross Infection, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Recurrence, United States, Bacterial Typing Techniques, Incidence, Clostridioides difficile, Electrophoresis, Gel, Pulsed-Field, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Burden of Clostridium difficile Infection in the United States

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks